CN104507476B - 含奈帕坦特的儿科口服液体组合物 - Google Patents
含奈帕坦特的儿科口服液体组合物 Download PDFInfo
- Publication number
- CN104507476B CN104507476B CN201380036967.9A CN201380036967A CN104507476B CN 104507476 B CN104507476 B CN 104507476B CN 201380036967 A CN201380036967 A CN 201380036967A CN 104507476 B CN104507476 B CN 104507476B
- Authority
- CN
- China
- Prior art keywords
- nepatant
- tpgs
- pharmaceutical composition
- oral pharmaceutical
- liquid aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000331A ITRM20120331A1 (it) | 2012-07-12 | 2012-07-12 | Composizioni pediatriche orali liquide contenenti nepadutant. |
| ITRM2012A000331 | 2012-07-12 | ||
| PCT/IB2013/055754 WO2014009926A1 (en) | 2012-07-12 | 2013-07-12 | Pediatric oral liquid compositions containing nepadutant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104507476A CN104507476A (zh) | 2015-04-08 |
| CN104507476B true CN104507476B (zh) | 2017-10-17 |
Family
ID=46939841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380036967.9A Expired - Fee Related CN104507476B (zh) | 2012-07-12 | 2013-07-12 | 含奈帕坦特的儿科口服液体组合物 |
Country Status (32)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11504362B2 (en) | 2017-06-09 | 2022-11-22 | Exelixis, Inc. | Liquid dosage forms to treat cancer |
| KR102640323B1 (ko) * | 2021-11-30 | 2024-02-27 | 대우제약 주식회사 | 사이클로스포린의 안정한 나노 현탁액 |
| CN120936344A (zh) * | 2023-01-27 | 2025-11-11 | 海罗利斯发展公司 | 维生素e tpgs作为用于苦味药物的味道掩蔽剂的用途 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101052386A (zh) * | 2004-10-27 | 2007-10-10 | 圭多提实验室有限公司 | 儿科使用的基于nk2拮抗剂的药物组合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9203804A (es) | 1987-10-19 | 1992-07-01 | Liposome Co Inc | Sistemas farmaceuticos a base de tocoferol. |
| GB9409778D0 (en) | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
| HU215966B (hu) | 1994-11-21 | 1999-07-28 | BIOGAL Gyógyszergyár Rt. | Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum |
| IT1277835B1 (it) | 1995-03-13 | 1997-11-12 | Menarini Farma Ind | Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche |
| MY126358A (en) | 1996-03-22 | 2006-09-29 | Glaxo Group Ltd | Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs |
| AU730216B2 (en) | 1996-09-01 | 2001-03-01 | Pharmos Corporation | Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| US5891845A (en) | 1997-11-21 | 1999-04-06 | Fuisz Technologies Ltd. | Drug delivery systems utilizing liquid crystal structures |
| AR025587A1 (es) | 1999-09-13 | 2002-12-04 | Hoffmann La Roche | Formulaciones en dispersion que contienen inhibidores de lipasa |
| DE10111058A1 (de) * | 2001-03-08 | 2002-09-12 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten |
| ITRM20030153A1 (it) | 2003-04-03 | 2004-10-04 | Exall S R L | Formulazione idrosolubile contenente ubichinone per uso oftalmico. |
| US20060068007A1 (en) | 2004-09-24 | 2006-03-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | Class of surfactant-like materials |
| EP1712220A1 (en) * | 2005-04-15 | 2006-10-18 | PARI GmbH Spezialisten für effektive Inhalation | Pharmaceutical aerosol composition |
-
2012
- 2012-07-12 IT IT000331A patent/ITRM20120331A1/it unknown
-
2013
- 2013-07-11 TW TW102124879A patent/TWI592167B/zh not_active IP Right Cessation
- 2013-07-12 GE GEAP201313731A patent/GEP201606586B/en unknown
- 2013-07-12 NZ NZ703090A patent/NZ703090A/en not_active IP Right Cessation
- 2013-07-12 MA MA37845A patent/MA37845B2/fr unknown
- 2013-07-12 MX MX2015000491A patent/MX2015000491A/es unknown
- 2013-07-12 BR BR112015000647A patent/BR112015000647A2/pt not_active IP Right Cessation
- 2013-07-12 JP JP2015521135A patent/JP6014252B2/ja not_active Expired - Fee Related
- 2013-07-12 EP EP13765492.7A patent/EP2872137A1/en not_active Withdrawn
- 2013-07-12 EA EA201500128A patent/EA025618B1/ru not_active IP Right Cessation
- 2013-07-12 AU AU2013288231A patent/AU2013288231B2/en not_active Ceased
- 2013-07-12 HK HK15105436.4A patent/HK1204920A1/xx unknown
- 2013-07-12 PE PE2015000028A patent/PE20150865A1/es not_active Application Discontinuation
- 2013-07-12 KR KR1020157003757A patent/KR20150030766A/ko not_active Withdrawn
- 2013-07-12 IN IN966DEN2015 patent/IN2015DN00966A/en unknown
- 2013-07-12 US US14/414,449 patent/US9421268B2/en not_active Expired - Fee Related
- 2013-07-12 AP AP2014008224A patent/AP2015008224A0/xx unknown
- 2013-07-12 CA CA2878817A patent/CA2878817A1/en not_active Abandoned
- 2013-07-12 WO PCT/IB2013/055754 patent/WO2014009926A1/en not_active Ceased
- 2013-07-12 CN CN201380036967.9A patent/CN104507476B/zh not_active Expired - Fee Related
- 2013-07-12 SG SG11201500095PA patent/SG11201500095PA/en unknown
- 2013-12-07 UA UAA201501079A patent/UA112905C2/uk unknown
-
2014
- 2014-12-11 TN TN2014000515A patent/TN2014000515A1/fr unknown
-
2015
- 2015-01-06 CO CO15002159A patent/CO7240380A2/es unknown
- 2015-01-08 CL CL2015000053A patent/CL2015000053A1/es unknown
- 2015-01-08 GT GT201500001A patent/GT201500001A/es unknown
- 2015-01-11 IL IL236667A patent/IL236667A0/en unknown
- 2015-01-12 NI NI201500001A patent/NI201500001A/es unknown
- 2015-01-12 PH PH12015500070A patent/PH12015500070B1/en unknown
- 2015-02-09 CR CR20150064A patent/CR20150064A/es unknown
- 2015-02-11 EC ECIEPI20155163A patent/ECSP15005163A/es unknown
- 2015-02-11 ZA ZA2015/00978A patent/ZA201500978B/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101052386A (zh) * | 2004-10-27 | 2007-10-10 | 圭多提实验室有限公司 | 儿科使用的基于nk2拮抗剂的药物组合物 |
Non-Patent Citations (1)
| Title |
|---|
| Eastman to Manufacture Vitamin E TPGS NF Drug Solubilizer at Llangefni, Wales Plant;无;《PHARMACEUTICAL》;20000201;第1-2页 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3731870B1 (en) | Liquid oral formulations for pde v inhibitors | |
| US11103492B2 (en) | Compositions and kits for omeprazole suspension | |
| JP2021138748A (ja) | メトトレキサート製剤 | |
| US20210322306A1 (en) | Oral dissolvable film with high load of polymeric binder | |
| CN104507476B (zh) | 含奈帕坦特的儿科口服液体组合物 | |
| BR112019014712A2 (pt) | Tratamento médio que compreende a administração entérica de edaravona | |
| CA2835912A1 (en) | Pharmaceutical composition comprising fexofenadine | |
| EP3968955A1 (en) | Pharmaceutical oral liquid solution of ivacaftor | |
| WO2019162756A2 (en) | Liquid pharmaceutical compositions of anticancer drugs | |
| CN114681432B (zh) | 一种丁苯酞组合物及其用途 | |
| KR102011714B1 (ko) | 리세드론산 또는 그의 염 및 비타민d를 함유하는 경구용 에멀젼 조성물 및 그 제조방법 | |
| JP2004522698A (ja) | 医薬組成物のための香料系およびそのような組成物の製造方法 | |
| CN116209437A (zh) | 经口腔黏膜递送的丁苯酞组合物及其用途 | |
| KR102556874B1 (ko) | 비스포스포네이트 및 콜레칼시페롤을 함유하는 경구용 에멀젼 조성물 및 그 제조방법 | |
| OA17358A (en) | Pediatric oral liquid compositions containing nepadutant. | |
| KR101058860B1 (ko) | 수소화 코코-글리세라이드를 이용한 난용성 약물의 자가유화형 나노에멀젼 조성물 | |
| US12150930B2 (en) | Oral liquid compositions of Enzalutamide and method of manufacturing thereof | |
| EP4565243A1 (en) | Oral formulations of abiraterone acetate and method of manufacturing thereof | |
| KR20250041170A (ko) | 항경련제의 안정한 약제학적 경구용 액체 제형 | |
| CN119546305A (zh) | 泛raf激酶抑制剂的口服液体悬浮液 | |
| KR20070031065A (ko) | 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법 | |
| OA19944A (en) | Pharmaceutical composition comprising fexofenadine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1204920 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171017 Termination date: 20180712 |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1204920 Country of ref document: HK |